Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
University Medical Centre Ljubljana, Ljubljana, Slovenia
Department of Critical care medicine of West China Hospital, Chengdu, Sichuan, China
Dept. of Anesthesiolgy, Tongji hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Yeditepe University Hospital, Istanbul, Devlet Yolu, Ankara cad 102/104, Kozyatagi, Turkey
University Medical Center, Lubbock, Texas, United States
University of Debrecen Medical and Health Science Center Department of Anesthesiology and Intensive Care, Debrecen, Hungary
Chonnam National University Hwasun Hospital, Hwasun, Jeollanamdo, Korea, Republic of
Seoul National University Hospital, Seoul, Korea, Republic of
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.